Closed Breathing System (CBS) Patent Portfolio for Sale Closed - PowerPoint PPT Presentation

Closed Breathing System (CBS) Patent Portfolio for Sale

Closed Breathing System (CBS) Patent Portfolio The information in this package is provided for the sole purpose of supporting the independent evaluation of these patents by prospective buyers, and does not constitute legal opinion or representation. Whilst Kapea will support the buyer in e.g. claim interpretation, the buyer is solely responsible for determining the potential use of these patents.

Closed Breathing System (CBS) Patent Portfolio Overview Patents 3 US patents 2 CA patents Kapea is exclusively representing a portfolio of 13 issued 1 JP patent patents that relate to a Closed Breathing System for 1 AU patent ventilators. 1 GB, IT, DE, FR, ES, SE patent The system includes the following components: ‣ an endotracheal tube Technology areas Endotracheal tube Cuff ‣ a cuff Humidifier ‣ a humidifier Priority dates 1998-2000 The sales package also includes other intellectual assets such Bid deadline as cad drawings, documentation. The inventor is also happy 1 July 2013 to assist with know-how transfer. Contact This is a unique opportunity for a company active in the Per Wendin, Partner business of ventilation systems or breathing systems to per.wendin@kapea.se acquire a novel system with huge market potential. +46 709 154806

Closed Breathing System (CBS) Patent Portfolio Patents The Patents 3 US patents There are three (3) patent families within the portfolio. We have listed the 2 CA patents US patent number for each family. All patents are in force and un- 1 JP patent 1 AU patent licensed. 1 GB, IT, DE, FR, ES, SE patent Family Name Countries US patent number Technology areas Endotracheal tube US, Japan, Canada US6634360 1 Endotracheal tube Cuff Humidifier US US7207972 2 Cuff Priority dates 1998-2000 US, Australia, US6941945 3 Humidifier Bid deadline Canada, Germany, 1 July 2013 Great Britain, Italy, Contact France, Spain, Per Wendin, Partner Sweden per.wendin@kapea.se +46 709 154806

Closed Breathing System (CBS) Patent Portfolio Seller Information Patents 3 US patents Mr. Björn Silfvercreutz is the inventor of this technology and the CEO 2 CA patents of Aloro Medical (www.aloromedical.com). He holds an M.Sc in 1 JP patent mechanics from the Royal Institute of Technology, Stockholm along 1 AU patent with a degree in Business Administration. 1 GB, IT, DE, FR, ES, SE Mr. Sifvercreutz has a solid background in marketing and sales in the patent medical device industry. He began a successful career as Sales Manager at Pfizer´s Orthopaedic Division. He joined thereafter a variety Technology areas of companies in life science in the position as Sales and Marketing Endotracheal tube director. BD (Becton Dickinson), the international producer of single- Cuff use products, was one of the successful companies where special Humidifier focus was addressed to high volume sales. Since 2006 Mr. Sifvercreutz has dedicated his work to Aloro Medical. Priority dates 1998-2000 Mr. Sifvercreutz received the SKAPA Innovation Reward 2002 for the work with the CBS system now for sale. Bid deadline 1 July 2013 Broker Information Contact Kapea AB (www.kapea.se) is an IP consulting company specialised in Per Wendin, Partner the commercialisation of IP . per.wendin@kapea.se +46 709 154806

Closed Breathing System (CBS) Patent Portfolio Sales process Patents 3 US patents The dead-line for bidding is set to 1 July 2013. 2 CA patents 1 JP patent Potential buyers shall fill-out and sign the term-sheet on http://www.kapea.se/ 1 AU patent sida2.html and send to per.wendin@kapea.se no later than 1 July 2013. 1 GB, IT, DE, FR, ES, SE patent No price floor has been set. The Seller reserves the right to accept or reject any offer in his sole discretion. All patents will be sold together as a package, ie. Technology areas neither patent families nor patents within a family will be sold separately. Endotracheal tube Cuff Alternatively, potential buyers can ask for a six month due diligence period at the Humidifier fixed cost of 35,000 USD (non refundable). Kapea together with the Seller shall be happy to assist buyer with additional information during said period. Priority dates 1998-2000 Once the Seller has accepted an offer presented by Kapea, the final agreement will be between the Seller and the buyer only, and Kapea shall not be part of the Bid deadline agreement. Parallel discussions will be held in strict confidence and no potential 1 July 2013 buyer shall have an exclusive right to the material provided by Kapea and Seller. Contact Per Wendin, Partner per.wendin@kapea.se Confidential information regarding the technology with be disclosed under NDA. +46 709 154806